triflupromazine has been researched along with Coronary Disease in 1 studies
Triflupromazine: A phenothiazine used as an antipsychotic agent and as an antiemetic.
triflupromazine : A member of the class of phenothiazines that is 10H-phenothiazine having a trifluoromethyl subsitituent at the 2-position and a 3-(dimethylamino)propyl group at the N-10 position.
Coronary Disease: An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gabauer, I | 1 |
| Slezák, J | 1 |
| Styk, J | 1 |
| Okolicány, J | 1 |
| Holec, V | 1 |
1 other study available for triflupromazine and Coronary Disease
| Article | Year |
|---|---|
[The effect of phenothiazines on reperfusion of the ischemic myocardium].
Topics: Animals; Chlorpromazine; Coronary Circulation; Coronary Disease; Dogs; Myocardial Contraction; Trifl | 1985 |